EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSVVUG00000026775
Gene Symbol: DHCR24
3 Cross references
208 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSVVUG00000025191
Gene Symbol: HMGCR
3 Cross references
270 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSVVUG00000009011
Gene Symbol: PDPK1
3 Cross references
240 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase

Ensembl ID : ENSVVUG00000016710
Gene Symbol: HPD
3 Cross references
204 Possible Orthologues:

40s Ribosomal Protein S15a

Ensembl ID : ENSVVUG00000028803
Gene Symbol: LOC112915184
3 Cross references
145 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSVVUG00000019703
Gene Symbol: NT5E
3 Cross references
249 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSVVUG00000016034
Gene Symbol: HTR1B
3 Cross references
245 Possible Orthologues:

5-Hydroxytryptamine Receptor 1d

Ensembl ID : ENSVVUG00000026875
Gene Symbol: HTR1D
3 Cross references
67 Possible Orthologues:

5-Hydroxytryptamine Receptor 1e

Ensembl ID : ENSVVUG00000009769
Gene Symbol: HTR1E
3 Cross references
155 Possible Orthologues:

5-Hydroxytryptamine Receptor 2a

Ensembl ID : ENSVVUG00000028338
Gene Symbol: HTR2A
3 Cross references
218 Possible Orthologues:

5-Hydroxytryptamine Receptor 2b

Ensembl ID : ENSVVUG00000025612
Gene Symbol: HTR2B
3 Cross references
204 Possible Orthologues:

5-Hydroxytryptamine Receptor 2c

Ensembl ID : ENSVVUG00000010582
Gene Symbol: HTR2C
3 Cross references
223 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).